GITR+ regulatory T cells in the treatment of autoimmune diseases.

[1]  C. Riccardi,et al.  Expansion of regulatory GITR+CD25low/-CD4+ T cells in systemic lupus erythematosus patients , 2014, Arthritis Research & Therapy.

[2]  E. Gelfand,et al.  JNK2 Regulates the Functional Plasticity of Naturally Occurring T Regulatory Cells and the Enhancement of Lung Allergic Responses , 2014, The Journal of Immunology.

[3]  S. Sakaguchi,et al.  TREG-cell therapies for autoimmune rheumatic diseases , 2014, Nature Reviews Rheumatology.

[4]  C. Riccardi,et al.  GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling. , 2014, Cell reports.

[5]  H. Einsele,et al.  Human regulatory T cells are selectively activated by low‐dose application of the CD28 superagonist TGN1412/TAB08 , 2014, European journal of immunology.

[6]  H. Akbari,et al.  Iranian Journal of Basic Medical Sciences Numerical Status of Cd4 + Cd25 + Foxp3 + and Cd8 + Cd28 - Regulatory T Cells in Multiple Sclerosis , 2022 .

[7]  C. Sautès-Fridman,et al.  The immune contexture of primary and metastatic human tumours. , 2014, Current opinion in immunology.

[8]  M. Farrar,et al.  Tumor necrosis factor receptor superfamily costimulation couples T cell receptor signal strength to thymic regulatory T cell differentiation , 2014, Nature Immunology.

[9]  Lei Lu,et al.  Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs , 2014, Journal of Translational Medicine.

[10]  R. de Waal Malefyt,et al.  Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4+ T Cells , 2014, Front. Immunol..

[11]  Elizabeth Whalen,et al.  Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients , 2013, PloS one.

[12]  M. Roncarolo,et al.  Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells , 2013, Front. Immunol..

[13]  F. Carbone,et al.  Regulatory T cell proliferative potential is impaired in human autoimmune disease , 2013, Nature Medicine.

[14]  D. Klatzmann,et al.  Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. , 2013, The lancet. Diabetes & endocrinology.

[15]  B. Nakken,et al.  Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders. , 2013, Human immunology.

[16]  A. D. De Groot,et al.  Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics , 2013, Expert review of clinical pharmacology.

[17]  C. Roura-mir,et al.  Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. , 2013, International immunology.

[18]  C. Riccardi,et al.  Characterization of CD4+ and CD8+ Tregs in a Hodgkin's lymphoma patient presenting with myasthenia-like symptoms. , 2013, Ideggyogyaszati szemle.

[19]  J. Wolchok,et al.  GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability , 2013, Cancer Immunology Research.

[20]  V. Shaygannejad,et al.  Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms , 2013, Journal of Neuroimmunology.

[21]  S. Rutella,et al.  FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents , 2013, BioMed research international.

[22]  G. Dranoff,et al.  Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies , 2013, The Journal of experimental medicine.

[23]  C. Riccardi,et al.  Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. , 2013, Rheumatology.

[24]  A. Levine,et al.  Impairment of regulatory T-cell function in autoimmune thyroid disease. , 2013, Thyroid : official journal of the American Thyroid Association.

[25]  J. Myśliwska,et al.  Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. , 2013, Human immunology.

[26]  D. Tiezzi,et al.  Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL‐17A expression and invasiveness of the tumor , 2013, European journal of immunology.

[27]  Nunzio Bottini,et al.  In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes. , 2013, Bioconjugate chemistry.

[28]  C. M. Bonin,et al.  Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection. , 2013, Revista da Sociedade Brasileira de Medicina Tropical.

[29]  H. Nie,et al.  Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis , 2013, Nature Medicine.

[30]  Sebastian M. Armasu,et al.  Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer , 2013, PloS one.

[31]  Kumar Kuna,et al.  Research Highlights and Editors’ Picks , 2013 .

[32]  M. Moniuszko,et al.  Lower proportions of CD4+CD25high and CD4+FoxP3, but not CD4+CD25+CD127low FoxP3+T cell levels in children with autoimmune thyroid diseases , 2013, Autoimmunity.

[33]  M. Peppelenbosch,et al.  Activated tumor‐infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer , 2013, Hepatology.

[34]  J. Ha,et al.  Subpopulations of Regulatory T Cells in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Behcet's Disease , 2012, Journal of Korean medical science.

[35]  D. Perry,et al.  Autologous Regulatory T Cells for the Treatment of Type 1 Diabetes , 2012, Current Diabetes Reports.

[36]  C. Riccardi,et al.  Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New , 2012, Clinical & developmental immunology.

[37]  M. Levings,et al.  Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers , 2012, Immunology.

[38]  Yijun Carrier,et al.  Enhanced GITR/GITRL interactions augment IL‐27 expression and induce IL‐10‐producing Tr‐1 like cells , 2012, European journal of immunology.

[39]  G. Scott,et al.  Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent , 2012, PloS one.

[40]  W. Hawthorne,et al.  Adoptive Transfer With In Vitro Expanded Human Regulatory T Cells Protects Against Porcine Islet Xenograft Rejection via Interleukin-10 in Humanized Mice , 2012, Diabetes.

[41]  C. Riccardi,et al.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives , 2012, British journal of pharmacology.

[42]  J. Wolchok,et al.  Modulation of GITR for cancer immunotherapy. , 2012, Current opinion in immunology.

[43]  E. Gelfand,et al.  Loss of T Regulatory Cell Suppression following Signaling through Glucocorticoid-induced Tumor Necrosis Receptor (GITR) Is Dependent on c-Jun N-terminal Kinase Activation* , 2012, The Journal of Biological Chemistry.

[44]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[45]  T. Geiger,et al.  Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function. , 2012, Human immunology.

[46]  Guangjie Chen,et al.  IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis , 2012, Journal of Neuroimmunology.

[47]  E. Fischer-Fodor,et al.  Gitr-Expressing Regulatory T-Cell Subsets are Increased in Tumor-Positive Lymph Nodes from Advanced Breast Cancer Patients as Compared to Tumor-Negative Lymph Nodes , 2012, International journal of immunopathology and pharmacology.

[48]  M. Roncarolo,et al.  The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells , 2011, Front. Immun..

[49]  S. Sengupta,et al.  Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. , 2011, Neuro-oncology.

[50]  H. Ikeuchi,et al.  The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy. , 2011, Cytokine.

[51]  E. Shevach,et al.  Polyclonal Treg cells modulate T effector cell trafficking , 2011, European journal of immunology.

[52]  M. Edinger,et al.  Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. , 2011, Current opinion in immunology.

[53]  Z. Amoura,et al.  Human FoxP3+ regulatory T cells in systemic autoimmune diseases. , 2011, Autoimmunity reviews.

[54]  C. Riccardi,et al.  CD4+CD25lowGITR+ cells: A novel human CD4+ T‐cell population with regulatory activity , 2011, European journal of immunology.

[55]  T. Akamizu,et al.  Association of functional GITR gene polymorphisms related to expression of glucocorticoid‐induced tumour necrosis factor‐receptor (GITR) molecules with prognosis of autoimmune thyroid disease , 2011, Clinical and experimental immunology.

[56]  Yi Wang,et al.  Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease , 2011, Journal of digestive diseases.

[57]  S. Quataert,et al.  Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T–Cell Compartment in the 1st Year of Human Type 1 Diabetes , 2011, Diabetes.

[58]  Hong Xiao,et al.  TRAIL Is Associated with Impaired Regulation of CD4+CD25− T Cells by Regulatory T Cells in Patients with Rheumatoid Arthritis , 2011, Journal of Clinical Immunology.

[59]  M. Grimm,et al.  Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa. , 2011, Cancer biomarkers : section A of Disease markers.

[60]  Cong-hua Wang,et al.  Combined Treatment of Etanercept and MTX Reverses Th1/Th2, Th17/Treg Imbalance in Patients with Rheumatoid Arthritis , 2011, Journal of Clinical Immunology.

[61]  G. Ning,et al.  Impairment of Regulatory Capacity of CD4+CD25+ Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves’ Disease , 2011, The Journal of Immunology.

[62]  M. Vatn,et al.  Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients , 2011, Scandinavian journal of gastroenterology.

[63]  J. Myśliwska,et al.  Lower Frequency of CD62Lhigh and Higher Frequency of TNFR2+ Tregs Are Associated with Inflammatory Conditions in Type 1 Diabetic Patients , 2011, Mediators of inflammation.

[64]  B. Falini,et al.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.

[65]  S. Sakaguchi,et al.  FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents. , 2011, Trends in pharmacological sciences.

[66]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[67]  Q. Ouyang,et al.  Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes , 2010, The Journal of Immunology.

[68]  S. Sakaguchi,et al.  Regulatory T cells in tumor immunity , 2010, International journal of cancer.

[69]  Loise M. Francisco,et al.  The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.

[70]  N. Rothman,et al.  Risk of Meningioma and Common Variation in Genes Related to Innate Immunity , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[71]  T. Chatila,et al.  GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. , 2010, International immunology.

[72]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[73]  Li Tang,et al.  An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand , 2010, Cellular and Molecular Immunology.

[74]  H. Waldmann,et al.  Enhancement of humoral and cellular immunity with an anti‐glucocorticoid‐induced tumour necrosis factor receptor monoclonal antibody , 2010, Immunology.

[75]  J. Myśliwska,et al.  First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. , 2009, Clinical immunology.

[76]  M. Gaub,et al.  Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease , 2009, Digestive Diseases and Sciences.

[77]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[78]  N. Müller,et al.  Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand1 , 2009, The Journal of Immunology.

[79]  M. Górska,et al.  Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. , 2009, Acta biochimica Polonica.

[80]  L. Boon,et al.  GITR Triggering Induces Expansion of Both Effector and Regulatory CD4+ T Cells In Vivo1 , 2009, The Journal of Immunology.

[81]  J. Bluestone,et al.  Plasticity of CD4(+) FoxP3(+) T cells. , 2009, Current opinion in immunology.

[82]  K. Kawa,et al.  The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease , 2009, Clinical and experimental immunology.

[83]  J. Mate,et al.  Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis , 2009, Endocrine.

[84]  C. Riccardi,et al.  Identification of regulatory T cells in systemic lupus erythematosus. , 2009, Autoimmunity reviews.

[85]  J. Shimizu,et al.  In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. , 2008, Immunology letters.

[86]  M. Farrar,et al.  IL-2, -7, and -15, but Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development1 , 2008, The Journal of Immunology.

[87]  H. Wiendl,et al.  The role of regulatory T cells in multiple sclerosis , 2008, Nature Clinical Practice Neurology.

[88]  C. Hsieh,et al.  A two-step process for thymic regulatory T cell development. , 2008, Immunity.

[89]  M. Farrar,et al.  Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. , 2008, Immunity.

[90]  E. Gambineri,et al.  Role of regulatory T cells and FOXP3 in human diseases. , 2007, The Journal of allergy and clinical immunology.

[91]  M. Battaglia,et al.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.

[92]  W. Strober,et al.  Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β , 2007, The Journal of Immunology.

[93]  S. Cuzzocrea,et al.  GITR/GITRL: More than an effector T cell co‐stimulatory system , 2007, European journal of immunology.

[94]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[95]  P. Emery,et al.  Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. , 2006, Rheumatology.

[96]  J. Lifson,et al.  Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro , 2006, Clinical and Vaccine Immunology.

[97]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[98]  C. Riccardi,et al.  GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice , 2006, Gut.

[99]  J. Shimizu,et al.  Control of Autoimmune Myocarditis and Multiorgan Inflammation by Glucocorticoid-Induced TNF Receptor Family-Related Proteinhigh, Foxp3-Expressing CD25+ and CD25− Regulatory T Cells1 , 2006, The Journal of Immunology.

[100]  M. Colombo,et al.  Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. , 2006, Cancer research.

[101]  M. Battaglia,et al.  Tr1 cells: from discovery to their clinical application. , 2006, Seminars in immunology.

[102]  J. Buer,et al.  Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells1 , 2006, The Journal of Immunology.

[103]  P. Debré,et al.  The immune paradox of sarcoidosis and regulatory T cells , 2006, The Journal of experimental medicine.

[104]  E. Mazzon,et al.  Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines. , 2006, Blood.

[105]  Gerd Ritter,et al.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[106]  T. Nomura,et al.  Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells , 2005, The Journal of experimental medicine.

[107]  E. Mazzon,et al.  Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  Ethan M. Shevach,et al.  Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells , 2004, The Journal of Immunology.

[109]  Tetsuya Nakamura,et al.  CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells1 , 2004, The Journal of Immunology.

[110]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[111]  W. Kuis,et al.  CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.

[112]  O. Lassila,et al.  Phenotypic characterization of regulatory T cells in the human decidua , 2004, Clinical and experimental immunology.

[113]  C. Riccardi,et al.  Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations , 2004, European journal of immunology.

[114]  H. Waldmann,et al.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  D. Bourdette,et al.  Functional assay for human CD4+CD25+ Treg cells reveals an age‐dependent loss of suppressive activity , 2003, Journal of neuroscience research.

[116]  Tetsuya Nakamura,et al.  Regulation of Murine Inflammatory Bowel Disease by CD25+ and CD25− CD4+ Glucocorticoid-Induced TNF Receptor Family-Related Gene+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[117]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[118]  C. Riccardi,et al.  GITR interacts with the pro-apoptotic protein Siva and induces apoptosis , 2002, Cell Death and Differentiation.

[119]  Manuela Battaglia,et al.  Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells , 2002, The Journal of experimental medicine.

[120]  P. Pandolfi,et al.  Role of GITR in activation response of T lymphocytes. , 2002, Blood.

[121]  D. Zélénika,et al.  Regulatory T Cells Overexpress a Subset of Th2 Gene Transcripts1 , 2002, The Journal of Immunology.

[122]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[123]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[124]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[125]  J. Wang,et al.  Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation. , 2014, European review for medical and pharmacological sciences.

[126]  J. Maher,et al.  Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time? , 2014, Clinical immunology.

[127]  C. Riccardi,et al.  GITR: a modulator of immune response and inflammation. , 2009, Advances in experimental medicine and biology.